Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Inmune Bio Inc (INMB)

79 + Investors. Track Smart Money conviction in INMB. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +6
Streak
2Q ▲
Buyers last Q
56%

Smart Money Signals — INMB

Based on 80 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added INMB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 92% of 3.0Y peak

92% of all-time peak
80 funds currently hold this stock — 92% of the 3.0-year high of 87 funds (reached 2025 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding INMB is almost the same as a year ago (+0 funds, +0% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 56% buying

43 buying34 selling
Last quarter: 43 funds bought or added vs 34 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~18 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 27 → 15 → 13 → 18. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 39% long-term, 32% new

39% conviction (2yr+) 29% medium 32% new
Of the 80 current holders: 31 (39%) held >2 years, 23 held 1–2 years, and 26 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares +4%, value -20%

Value
-19%
Shares
+3%
Last quarter: funds added +4% more shares while total portfolio value only changed -20%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

18 → 27 → 15 → 13 → 18 new funds/Q
New funds entering each quarter: 27 → 15 → 13 → 18. INMB is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 45% veterans vs 39% newcomers

45% veterans 17% 1-2yr 39% new
Entry-cohort mix of 83 holders: 37 (45%) are 2+ year veterans, 14 entered 1–2 years ago, and 32 (39%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
26 of 79 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in INMB. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — INMB

In 2026 Q1, 43 hedge funds were net buyers of INMB (18 opened a new position, 25 added to an existing one), while 34 reduced or exited (22 trimmed, 12 sold completely) — a 56% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 40% of total institutional value in INMB is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +6 funds (more new holders than closures). Total institutional holders: 80.

Hedge Fund Ownership: INMB

How many hedge funds hold INMB — quarterly history vs. share price
Quarterly hedge fund ownership of INMB vs. share price

Market Analysis: INMB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: INMB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Inmune Bio Inc (INMB) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much INMB has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 83d ago
INMB
+26.5%
XLV
+708.5%

INMB outperformed XLV by -682.0% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 38d ago
INMB
-7.7%
XLV
+695.4%

Since the filing became public, INMB outperformed XLV by -703.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

13 top-rated funds 0 high-conviction
Consensus
5.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: INMB
79 + Investors

Track Smart Money conviction in INMB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 79 74 6.76%
13F Shares 5M 5M 3.48%
Total Value $7M $8M -19.79%
New Positions 17 13 +4
Increased Positions 24 23 +1
Closed Positions 12 11 +1
Reduced Positions 21 22 -1
Total Calls 3 2 50.0%
Total Puts 1 1 -
PUT/CALL Ratio 0.33 0.5 Bullish

Statistics: INMB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

79 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in INMB. Verified SEC 13F-HR filings.

QUARTER:
Top 25 INMB holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Dauntless Investment Group, LLC 0.14% 183,476 $207K
2 Westside Investment Management, Inc. 0.02% 108,300 $122K
3 Two Sigma Securities, LLC 0.00% 14,530 $16K
4 Laird Norton Wetherby Trust Company, LLC 0.00% 50,000 $56K
5 Essential Partners LLC 0.00% 2,171 $2K
6 XTX Topco Ltd 0.00% 30,306 $34K
7 Focus Partners Advisor Solutions, LLC 0.00% 43,025 $49K
8 Quadrature Capital Ltd 0.00% 32,362 $37K
9 Tower Research Capital LLC (TRC) 0.00% 11,772 $13K
10 Modera Wealth Management, LLC 0.00% 17,575 $20K
11 Aqr Capital Management LLC 0.00% 270,317 $305K
12 Ieq Capital, LLC 0.00% 24,563 $28K
13 Leonteq Securities AG 0.00% 2,500 $3K
14 GAMMA Investing LLC 0.00% 1,604 $2K
15 Raymond James Financial Inc 0.00% 203,245 $230K
16 Beacon Pointe Advisors, LLC 0.00% 10,368 $12K
17 DAVENPORT & Co LLC 0.00% 10,000 $11K
18 Wealth Preservation Advisors, LLC 0.00% 60
19 UBS Group AG 0.00% 253,340 $286K
20 Ameritas Investment Partners, Inc. 0.00% 1,196 $1K
21 LMR Partners LLP 0.00% 16,600 $19K
22 Cwm, LLC 0.00% 13,120 $15K
23 Keating Financial Advisory Services, Inc. 0.00% 200
24 Vanguard Fiduciary Trust Co 0.00% 123,184 $139K
25 Rothschild Investment LLC 0.00% 585
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Inmune Bio Inc (INMB)

What does the Smart Money Trend signal show for INMB?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added INMB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for INMB?

Slight buying edge — 56% buying: Last quarter: 43 funds bought or added vs 34 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for INMB holders?

Elite ownership — 40% AUM from top-100 funds: 26 of 79 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in INMB. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held INMB?

Mixed — 39% long-term, 32% new: Of the 80 current holders: 31 (39%) held >2 years, 23 held 1–2 years, and 26 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Inmune Bio Inc (INMB) following the 2026 Q1 hedge fund 13F filings?

As of today, INMB has moved -7.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +695.4% for the XLV sector ETF — an outperformance of -703.1%. Since the quarter end (March 31, 2026), INMB has gained +26.5% vs +708.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →